Want a bigger picture? Try a FREE sample of this report now!
See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.
Overview of the global prenatal DNA sequencing market
Globally, the prevalence of chronic diseases such as cancer and diabetes is increasing, driving the need for advanced healthcare models. Due to the growing prevalence of chronic diseases, the R&D investments for the discovery of new diagnostics tools are increasing. Supported by technological advances in precise detection and early diagnosis, medical practitioners are focusing on reducing the cost of the treatment. Technavio’s market study identifies the growing prevalence of cancer to be one of the primary growth factors for the prenatal DNA sequencing market. Also, the increasing number of genome and DNA mapping projects are consequent in increased knowledge about genome sequencing and molecular diagnostics. These factors will significantly propel the parental DNA sequencing market value. This efficient diagnosis of diseases and pathways increases the development of personalized treatment. Our market analysts estimate that the market will grow steadily at a CAGR of close to 14% by 2022 and will augment the prenatal DNA sequencing market value.
The growing technological improvements in DNA sequencing is one of the major prenatal DNA sequencing trends that will drive the growth of the market during the upcoming period. Technological improvements in genome sequencing, primarily DNA sequencing, are frequent. In 1977, the Sanger’s method of sequencing was the first-generation method of sequencing clonal DNA populations. Supported by rapid technological advancements, next-generation sequencing (NGS) is gaining popularity as it can analyze multiple genomes simultaneously.
Companies covered
According to the prenatal DNA sequencing market dynamics, this market appears to be moderately fragmented owing to the presence of numerous vendors. This prenatal DNA testing market research report offers a detailed analysis of the market’s competitive environment and provides information on the measures adopted by vendors to sustain in this competitive market. Additionally, to help clients improve their revenue shares, Technavio’s analysts also recommend key areas the companies should focus on and the strategies they should follow.
This research report provides an analysis of various companies in the market including
- Agilent Technologies
- BGI
- F. Hoffmann-La Roche
- Illumina
- Laboratory Corporation of America
- Natera
Segmentation by application and analysis of the prenatal DNA sequencing market
- Genetic diseases
- Non-genetic diseases
Based on application, the genetic disease segment will dominate the shares of the prenatal DNA testing market until the end of the forecast period. This application segment will grow steadily owing to the high global prevalence of genetic disorders and pregnancies.
Geographical segmentation and analysis of the prenatal DNA sequencing market
The Americas will be the major revenue contributor to the prenatal DNA testing market throughout the forecast period. In this region, the US dominated the revenue share followed by Canada and Brazil. This region witnesses steady growth due to the increased investments in healthcare research and prenatal testing.
Get more value with Technavio’s subscription platform! Gain easy access to all of Technavio’s reports, along with on-demand services. Try the demo
Key questions answered in the report include
- What will the market size and the growth rate be in 2022?
- What are the key factors driving the global prenatal DNA sequencing market?
- What are the key market trends impacting the growth of the global prenatal DNA sequencing market?
- What are the challenges to market growth?
- Who are the key vendors in the global prenatal DNA sequencing market?
- What are the market opportunities and threats faced by the vendors in the global prenatal DNA sequencing market?
- Trending factors influencing the market shares of the Americas, APAC, and EMEA.
- What are the key outcomes of the five forces analysis of the global prenatal DNA sequencing market?
Technavio also offers customization on reports based on specific client requirement.
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 05: MARKET SIZING
- Market definition
- Market sizing 2017
- Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 07: MARKET SEGMENTATION BY APPLICATION
- Segmentation by application
- Comparison by application
- Genetic diseases
- Non-genetic diseases
- Market opportunity by application
PART 08: CUSTOMER LANDSCAPE
PART 09: REGIONAL LANDSCAPE
- Geographical segmentation
- Regional comparison
- Americas
- EMEA
- APAC
- Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 12: MARKET TRENDS
- Increasing number of research activities on human genomics
- Growing technological improvements in DNA sequencing
- Increasing M&A
PART 13: VENDOR LANDSCAPE
- Overview
- Landscape disruption
PART 14: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Agilent Technologies
- BGI
- F. Hoffmann-La Roche
- Illumina
- Laboratory Corporation of America
- Natera
- Other prominent vendors
PART 15: APPENDIX